{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:38:29Z","timestamp":1790379509375,"version":"4.1.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.03058","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T08:45:23Z","timestamp":1545209123000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["The Pattern of Malignancies in Down Syndrome and Its Potential Context With the Immune System"],"prefix":"10.3389","volume":"9","author":[{"given":"Daniel","family":"Satg\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus G.","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000386035","article-title":"The concept of immunological surveillance","volume":"13","author":"Burnet","year":"1970","journal-title":"Prog Exp Tumor Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/annonc\/mds256","article-title":"Immuno-oncology: understanding the function and dysfunction of the immune system in cancer","author":"Finn","year":"2012","journal-title":"Ann Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2017.06.009","article-title":"Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders","volume":"141","author":"Hauck","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01149","article-title":"A tumor profile in primary immune deficiencies challenges the cancer immune surveillance concept","author":"Satg\u00e9","year":"2018","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","article-title":"Infections and immunodeficiency in Down syndrome","volume":"164","author":"Ram","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.0.CO;2-M","article-title":"A tumor profile in Down syndrome","volume":"78","author":"Satg\u00e9","year":"1998","journal-title":"Am J Med Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ddrr.1123","article-title":"People with intellectual disability: what do we know about adulthood and life expectancy?","volume":"18","author":"Coppus","year":"2013","journal-title":"Dev Disabil Res Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/ijc.21518","article-title":"Cancer incidence of persons with Down syndrome in Finland: a population-based study","volume":"118","author":"Patja","year":"2006","journal-title":"Int J Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/gim.2016.23","article-title":"Low risk of solid tumors in persons with Down syndrome","volume":"18","author":"Hasle","year":"2016","journal-title":"Genet Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1365-2788.2006.00862.x","article-title":"The profile and incidence of cancer in Down syndrome","volume":"51","author":"Sullivan","year":"2007","journal-title":"J Intellect Disabil Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ijc.11212","article-title":"Are solid tumours different in children with Down's syndrome?","volume":"106","author":"Satg\u00e9","year":"2003","journal-title":"Int J Cancer"},{"key":"B14","first-page":"448","article-title":"A lack of neuroblastoma in Down syndrome: a study from 11 European countries","volume":"58","author":"Satg\u00e9","year":"1998","journal-title":"Cancer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11060-012-1041-y","article-title":"A very rare cancer in Down syndrome: medulloblastoma","volume":"112","author":"Satg\u00e9","year":"2013","journal-title":"J Neurooncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1469-1809.2001.6520167.x","article-title":"Mortality and cancer incidence in persons with Down's syndrome, their parents and siblings","volume":"65","author":"Hermon","year":"2001","journal-title":"Ann Hum Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1471-0528.1993.tb12952.x","article-title":"Abnormal fetal immunological development in Down's syndrome","volume":"100","author":"Thilaganathan","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"B18","first-page":"88","article-title":"Immune function, infection and autoimmunity","author":"Arkwright","year":"2015","journal-title":"Down Syndrome Current Perspectives"},{"key":"B19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nature04678","article-title":"NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21","volume":"441","author":"Arron","year":"2006","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/archinte.163.6.705","article-title":"Mortality and cancer incidence among individuals with Down syndrome","volume":"163","author":"Hill","year":"2003","journal-title":"Arch Intern Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1093\/infdis\/jix168","article-title":"Quantitative, phenotypical, and functional characterization of cellular immunity in children and adolescents with Down syndrome","volume":"215","author":"Schoch","year":"2017","journal-title":"J Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2249.2009.03890.x","article-title":"Intrinsic defect of the immune system in children with Down syndrome: a review","volume":"156","author":"Kusters","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.jaci.2014.07.015","article-title":"Defective B-cell memory in patients with Down syndrome","volume":"134","author":"Verstegen","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.humimm.2016.05.004","article-title":"Altered immune parameters correlate with infection-related hospitalizations in children with Down syndrome","volume":"77","author":"Mart\u00ednez","year":"2016","journal-title":"Hum Immunol"},{"key":"B25","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1182\/blood.V77.6.1263.1263","article-title":"Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome","volume":"77","author":"Cossarizza","year":"1991","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1442-200X.2008.02761.x","article-title":"Elevated intracellular calcium in neutrophils in patients with Down syndrome","volume":"51","author":"Yamato","year":"2009","journal-title":"Pediatr Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.prrv.2017.07.003","article-title":"The evaluation and management of respiratory disease in children with Down syndrome (DS)","volume":"26","author":"Alsubie","year":"2018","journal-title":"Paediatr Respir Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1046\/j.1365-2788.2001.00322.x","article-title":"Cancer incidence among people with intellectual disability","volume":"45","author":"Patja","year":"2001","journal-title":"J Intellect Disabil Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10552-004-1256-0","article-title":"The incidence of cancer in people with intellectual disabilities","volume":"15","author":"Sullivan","year":"2004","journal-title":"Cancer Causes Control"},{"key":"B30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/bjh.12041","article-title":"Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder","volume":"159","author":"Gamis","year":"2012","journal-title":"Br J Haematol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02546","article-title":"Gastric cancer is the leading cause of death in Italian adult patients with common variable immunodeficiency","author":"Pulvirenti","year":"2018","journal-title":"Front Immunol."},{"key":"B32","author":"Satg\u00e9","year":"2006","journal-title":"Any Digestive Tract Tumor in Down Syndrome? About a Theoretical Risk and Practical Observation. Pediatrics P3Rs November"},{"key":"B33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ajmg.c.31511","article-title":"A tumor profile in Edwards syndrome (trisomy 18)","volume":"172","author":"Satg\u00e9","year":"2016","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/pd.1970140403","article-title":"Abnormal immunological development in fetuses with trisomy 18","volume":"14","author":"Makrydimas","year":"1994","journal-title":"Prenat Diagn"},{"key":"B35","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1159\/000095663","article-title":"Prenatally diagnosable differences in the cellular immunity of fetuses with Down's and Edwards' syndrome","volume":"21","author":"Zizka","year":"2006","journal-title":"Fetal Diagn Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in primary immunodeficiency diseases: cancer incidence in the United States immune deficiency network registry","volume":"141","author":"Mayor","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1182\/blood-2013-11-492231","article-title":"Antibody-modified T cells: CARs take the front seat for hematologic malignancies","volume":"123","author":"Maus","year":"2014","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1182\/blood-2010-03-272351","article-title":"Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?","volume":"116","author":"Vajdic","year":"2010","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc3355","article-title":"Tumorigenesis in Down's syndrome: big lessons from a small chromosome","volume":"12","author":"Ni\u017deti\u0107","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2017.08.014","article-title":"Mitochondria as pharmacological targets in Down syndrome","volume":"114","author":"Valenti","year":"2018","journal-title":"Free Radic Biol Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03058\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T17:58:35Z","timestamp":1573581515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03058\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2018.03058"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.03058","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,19]]},"article-number":"3058"}}